Skip to content
Loop Biz – Lifestyle
Author:
EndoCyclic Therapeutics
EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis
March 23, 2026